Daniel van den Bergh(61)
Kaiser Permanente Ventures Principal
location
Oakland, California
investment range
$5.0m - $12.0m
sweet spot
$7.0m
most interested in
Enterprise healthcare IT, digital health, healthcare services, medical technologynot interested in
We don't deploy capital in: (1) new molecule development, (2) outside of the US, (3) in businesses that compete directly with Kaiser Permanente (Medicare Advantage plans, for example).Daniel van den Bergh's Past Investments (10)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Ordr | Series B | $33.5M | Mar 2020 | |
| Nuvolo | Series B | $12M (Lead) | Jul 2019 | |
| NextHealth Technologies | Series B | $20M | Mar 2019 | |
| Collective Medical Technologies | Series A | $47.5M | Nov 2017 | |
| Protenus | Series A | $7M (Lead) | Jul 2017 | |
| QuantiaMD | Series E | $12M (Lead) | Aug 2013 | |
| Sotera Wireless | Series D1 | $15M (Lead) | May 2013 | |
| Prognos | Series B | $15M | May 2013 | |
| NuPathe | PIPE | $28M | Oct 2012 | |
| Putney Vet | Series C | $21M (Lead) | Sep 2011 |
Daniel van den Bergh's Education
The Wharton School MBA Healthcare and entrepreneurship
Cornell University BS Biological Engineering
Daniel van den Bergh's Media
No media found for Daniel van den Bergh.